thursday 21st, page-25

Wisdom I think you'll find by the time we treat 800 patients, one would expect that some will experience more than just flu like symptoms.

In our last phase 2a trial seven enrollees died before they could be treated, while only two of the 28 lived to receive 7 CVac injections. So not much to go by there when only 2 received the full treatment in regards to monitoring adverse effects to patients running the full course of the treatment? Did the rest die from the cancer alone or were other things happening in there body that we didn't fully examine because they were terminally ill anyway? Phase 11 b results next year will paint a clearer picture. Cheers